Discover a study where researchers have discovered a myeloid-derived antigen-presenting cells population essential for peripherally induced regulatory T cells.

Pfizer Inc. today announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care (SOC) Bacillus ...

Essential antioxidants and immune-boosting elements abound in Tonic Greens' 6-in-1 mix. It is a nutritional supplement ...